BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be ...

Among four approaches, perioperative chemotherapy and trimodality therapy were associated with better survival outcomes in ...

The European Commission approved Tevimbra, the commercial name for Tislelizumab, in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma and gastric or ...

BeiGene ($BGNE) shares jumped over 5% pre-market Wednesday, with the oncology company’s stock poised to reach a two-week high ...

Shares of BeiGene rose Wednesday morning after the company said it has received regulatory approval for its treatment of gastric and esophageal cancers from the European Union. Shares were recently up ...

Across the world, people love drinking endless cups of tea and coffee – that of piping. And now that cold weather is here, ...

The EC considered the treatment's activity in patients with advanced, PD-L1-positive esophageal and gastric cancers in the RATIONALE-305 and -306 trials.

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...

Achalasia is primarily caused by the degeneration of the myenteric plexus in the esophageal wall, leading to impaired ...

The combination of radiation, chemotherapy, and immunotherapy can reduce tumor size and lead to significantly better survival ...

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and ...